Kobayashi Sakiko, Yoshimura Noh Jaeduk, Shimizu Taeko, Sato Tomoaki, Kurihara Isao, Sugino Kiminori, Itoh Hiroshi, Ito Koichi
Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.
Endocr J. 2017 Feb 27;64(2):207-212. doi: 10.1507/endocrj.EJ16-0135. Epub 2016 Nov 30.
Familial dysalbuminemic hyperthyroxinemia (FDH) is an autosomal dominant condition and is the most commonly inherited euthyroid hyperthyroxinemia in Caucasians. However, it is extremely rare in Asian populations. A 30-year-old Japanese woman, who was incidentally found to have apparent thyroid dysfunction, was admitted to our hospital in 2004. She had extremely elevated serum free thyroxine (FT), moderately elevated free triiodothyronine (FT), and normal thyroid-stimulating hormone (TSH). Clinical thyroid examination revealed no abnormalities other than small goiter. Anti-thyroglobulin antibody titer was positive, but titers of other anti-thyroid antibodies, including antithyroid peroxidase antibody, TSH receptor antibodies, and thyroid-stimulating antibody, were negative. Levels of FT, FT, and TSH were similar when measured by three different laboratory kits, and FT was still high when measured by equilibrium dialysis. By affinity chromatography, FT, TT, and albumin were extracted to the same fraction, and the levels of FT and TT were extremely high. By combination of reversed phase liquid chromatography and mass spectrometry techniques, the amino acid sequence of human serum albumin was determined. The patient was found to be a heterozygote for p.R218P mutation in the gene for human serum albumin and was diagnosed as FDH. This patient, who harbored the p.R218P mutation in the albumin gene, is the fifth case report of FDH in Japan. This condition is characterized by extremely high serum FT and moderately high serum FT levels. Although rare, FDH should be considered in the differential diagnosis for syndrome of inappropriate secretion of TSH (SITSH) in Japan.
家族性异常白蛋白血症性甲状腺素血症(FDH)是一种常染色体显性疾病,是白种人中最常见的遗传性甲状腺功能正常的甲状腺素血症。然而,在亚洲人群中极为罕见。一名30岁的日本女性,偶然发现有明显的甲状腺功能障碍,于2004年入住我院。她的血清游离甲状腺素(FT)极度升高,游离三碘甲状腺原氨酸(FT)中度升高,促甲状腺激素(TSH)正常。临床甲状腺检查除小甲状腺肿外无其他异常。抗甲状腺球蛋白抗体滴度呈阳性,但包括抗甲状腺过氧化物酶抗体、TSH受体抗体和促甲状腺激素抗体在内的其他抗甲状腺抗体滴度均为阴性。用三种不同的实验室试剂盒检测时,FT、FT和TSH水平相似,用平衡透析法检测时FT仍很高。通过亲和层析,FT、TT和白蛋白被提取到同一组分中,FT和TT水平极高。通过反相液相色谱和质谱技术相结合,测定了人血清白蛋白的氨基酸序列。该患者被发现是人血清白蛋白基因p.R218P突变的杂合子,被诊断为FDH。该携带白蛋白基因p.R218P突变的患者是日本FDH的第五例病例报告。这种情况的特征是血清FT极高和血清FT中度升高。尽管罕见,但在日本,FDH在鉴别诊断促甲状腺激素不适当分泌综合征(SITSH)时应予以考虑。